Company profile: Hofseth BioCare
1.1 - Company Overview
Company description
- Provider of high-value biomarine ingredients for human applications using proprietary production technology to preserve protein, calcium, and oil from fish. Products include ProGo bioactive peptide powder from salmon offcuts, OmeGo full-spectrum salmon oil, Brilliant Salmon Oil, and HBC Immunology LLC developing peptides for cancer co-therapies; conducts R&D with medical universities and hospitals.
Products and services
- OmeGo®: A proprietary full-spectrum salmon oil containing all 21 fatty acids and omegas, engineered to deliver higher bioavailability and demonstrated health benefits versus processed omega-3 oils for human applications
- ProGo®: A proprietary bioactive peptide powder derived from fresh salmon offcuts, shown to regulate glucose, improve metabolic health, and support iron metabolism, skin health, and gut immune system balance
- HBC Immunology LLC: A peptide-based subsidiary developing peptides for cancer co-therapies, particularly targeting advanced prostate cancer and exploring other potential cancer indications within human applications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Hofseth BioCare
Before Brands
HQ: United States
Website
- Description: Provider of health and wellness products for young families.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Before Brands company profile →
Asantae
HQ: United States
Website
- Description: Provider of nutritional products marketed internationally and in the United States through direct and network marketing channels, including ingredients designed to reduce chronic low-grade inflammation and oxidative stresses, underlying conditions for various epidemic diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Asantae company profile →
NeoCell
HQ: United States
Website
- Description: Provider of US collagen supplements including Collagen + C (types 1 and 3 with vitamin C) for skin, hair, nails, and bones; hyaluronic acid capsules or liquid for skin hydration; collagen type 2 from chicken sternum for joint and cartilage health; marine collagen from fish; and collagen combined with biotin or hyaluronic acid.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NeoCell company profile →
Fortitech Premixes
HQ: United States
Website
- Description: Provider of custom nutrient premixes and tailored nutrient blends for the food, beverage, and pharmaceutical industries, developing and manufacturing formulations to meet specific nutritional needs and product requirements.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fortitech Premixes company profile →
Oragenics
HQ: United States
Website
- Description: Provider of development-stage therapeutics and vaccines, including lantibiotics targeting antibiotic-resistant, healthcare-acquired infections; neurosteroids ONP-002 for moderate to severe concussion and ONP-001 for Niemann Pick Type-C disease; and NT-CoV-2, an intranasal COVID-19 vaccine candidate designed to enhance mucosal immunity and reduce needle use.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oragenics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Hofseth BioCare
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Hofseth BioCare
2.2 - Growth funds investing in similar companies to Hofseth BioCare
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Hofseth BioCare
4.2 - Public trading comparable groups for Hofseth BioCare
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →